Maitenance therapy with bortezomib for multiple myeloma after autologus stem cell transplantation
Latest Information Update: 13 Dec 2018
Price :
$35 *
At a glance
- Drugs Bortezomib (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 05 Dec 2018 Status changed from recruiting to discontinued.
- 04 Feb 2012 New trial record